In Silico Meets In Vivo: Towards Computational CRISPR-Based SgRNA Design
Overview
Authors
Affiliations
CRISPR-based genome editing has been widely implemented in various cell types. In silico single guide RNA (sgRNA) design is a key step for successful gene editing using the CRISPR system, and continuing efforts are aimed at refining in silico sgRNA design with high on-target efficacy and reduced off-target effects. Many sgRNA design tools are available, but careful assessments of their application scenarios and performance benchmarks across different types of genome-editing data are needed. Efficient in silico models can be built that integrate current heterogeneous genome-editing data to derive unbiased sgRNA design rules and identify key features for improving sgRNA design. Comprehensive evaluation of on-target and off-target effects of sgRNA will allow more precise genome editing and gene therapies using the CRISPR system.
Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia.
Wu A, Liu X, Fruhstorfer C, Jiang X Int J Mol Sci. 2024; 25(6).
PMID: 38542279 PMC: 10970269. DOI: 10.3390/ijms25063307.
CRISPR-M: Predicting sgRNA off-target effect using a multi-view deep learning network.
Sun J, Guo J, Liu J PLoS Comput Biol. 2024; 20(3):e1011972.
PMID: 38483980 PMC: 10965074. DOI: 10.1371/journal.pcbi.1011972.
CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics.
Tiwari P, Ko T, Dubey R, Chouhan M, Tsai L, Singh H Front Mol Biosci. 2023; 10:1214489.
PMID: 37469704 PMC: 10352522. DOI: 10.3389/fmolb.2023.1214489.
Huszar K, Welker Z, Gyorgypal Z, Toth E, Ligeti Z, Kulcsar P Nucleic Acids Res. 2023; 51(11):5847-5863.
PMID: 37140059 PMC: 10287927. DOI: 10.1093/nar/gkad323.
CRISPR-Combo-mediated orthogonal genome editing and transcriptional activation for plant breeding.
Pan C, Qi Y Nat Protoc. 2023; 18(6):1760-1794.
PMID: 37085666 DOI: 10.1038/s41596-023-00823-w.